DE60224857D1 - Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose - Google Patents

Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose

Info

Publication number
DE60224857D1
DE60224857D1 DE60224857T DE60224857T DE60224857D1 DE 60224857 D1 DE60224857 D1 DE 60224857D1 DE 60224857 T DE60224857 T DE 60224857T DE 60224857 T DE60224857 T DE 60224857T DE 60224857 D1 DE60224857 D1 DE 60224857D1
Authority
DE
Germany
Prior art keywords
albumin
combination
growth factors
inhibit apoptosis
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224857T
Other languages
English (en)
Other versions
DE60224857T2 (de
Inventor
Kazuo Tsubota
Akihiro Higuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DE60224857D1 publication Critical patent/DE60224857D1/de
Publication of DE60224857T2 publication Critical patent/DE60224857T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60224857T 2001-04-26 2002-04-26 Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose Expired - Lifetime DE60224857T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001129472 2001-04-26
JP2001129472 2001-04-26
JP2001322051 2001-10-19
JP2001322051 2001-10-19

Publications (2)

Publication Number Publication Date
DE60224857D1 true DE60224857D1 (de) 2008-03-20
DE60224857T2 DE60224857T2 (de) 2009-02-05

Family

ID=26614286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224857T Expired - Lifetime DE60224857T2 (de) 2001-04-26 2002-04-26 Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose

Country Status (4)

Country Link
US (1) US6852687B2 (de)
EP (1) EP1254665B1 (de)
DE (1) DE60224857T2 (de)
ES (1) ES2300398T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1605336A (zh) * 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
TW201000135A (en) * 2008-05-15 2010-01-01 R Tech Ueno Ltd Pharmaceutical composition for treating xerophthalmia and/or disorder of cornea/conjunctiva
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2225398C (en) * 1996-04-19 2008-07-15 R-Tech Ueno, Ltd. Pharmaceutical composition comprising albumin as an active ingredient
JPH10158188A (ja) * 1996-11-29 1998-06-16 Senju Pharmaceut Co Ltd 角膜治療用組成物
IL120005A (en) * 1997-01-14 2000-08-31 Ramot University Authority Of Pharmaceutical compositions for the treatment of the eye
US6087395A (en) 1997-10-21 2000-07-11 Japan Science And Technology Corporation Isocarbacyclin derivatives as apoptosis inhibitors
US6495538B2 (en) * 1999-06-23 2002-12-17 Zinc Therapeutics, Canada Inc. Zinc ionophores as therapeutic agents
US6689165B2 (en) * 2000-03-31 2004-02-10 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Surface modifications for enhanced epithelialization

Also Published As

Publication number Publication date
US6852687B2 (en) 2005-02-08
ES2300398T3 (es) 2008-06-16
EP1254665B1 (de) 2008-01-30
DE60224857T2 (de) 2009-02-05
US20020187927A1 (en) 2002-12-12
EP1254665A1 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
DE60202077D1 (de) Spannungserhöhungs-schaltung mit bestimmung der versorgungsspannung zur kompensation von schwankungen der versorungsspannung beim lesen
DE60015082D1 (de) Künstliche peptide mit oberflächenaktivität und ihre verwendung zur herstellung von künstlichen tensiden
DE69502510T2 (de) Grenzschicht zur verwendung in kühlmöbeln
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE69810957D1 (de) Hocheffizienter absorbierender artikel zur verwendung mit monatshösche
DE60326874D1 (de) Neue verwendung von erythropoietin in herzerkrankungen
NO20003707L (no) FremgangsmÕte for Õ anrike levende for med næringsstoffer essensielle for fiskelarver
IL175736A0 (en) Muteins of fibroblast growth factor 21
DK1531819T3 (da) Anvendelse af ikappab kinaseinhibitorer i smertebehandlingen
DE60203463D1 (de) Vorichtung zur Bestimmung von physikalischen Informationen bezüglich Einschränkungen des täglichen Lebens in Beziehung
DE60225789D1 (de) Seitenleiste und mit der seitenleiste kombinierter ölabstreifring zur verminderung des ölverbrauchs
DE50212455D1 (de) Verwendung von Dimerdiolen
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE60122547D1 (de) Gasangetriebene pumpe zur verwendung im bohrloch
ATE313558T1 (de) Reinigung von hbv-antigenen zur verwendung in impfstoffen
DE60106928D1 (de) Rutheniumkomplexe und ihre verwendung zur asymmetrischen hydrierung
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
DE60211632D1 (de) Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität"
DE50113892D1 (de) Phosphacyclohexane und ihre verwendung in der hydroformylierung von olefinen
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
ATE390474T1 (de) Verwendung von polymerem material zur behandlung harter oberflächen
ATE400266T1 (de) N-acylaminoacetonitril-derivate und ihre verwendung zur kontrolle von parasiten
AU2003216389A8 (en) Induction of hair growth with vascular endothelial growth factor
DE60224857D1 (de) Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition